Paediatric porto-sinusoidal vascular disease: Two different clinical phenotypes with subtle histological differences
Angelo Di Giorgio1, Lorenza Matarazzo1, Aurelio Sonzogni2
1Paediatric Hepatology, Gastroenterology and Transplantation, Hospital Papa Giovanni XXIII, Bergamo, Italy.
Summary
Porto-sinusoidal vascular disease (PSVD) in children presents with two phenotypes: portal hypertension or elevated transaminases. While outcomes are favorable without portal hypertension, those with it may face complications, highlighting the need for PSVD recognition.
Area of Science:
- Pediatric Gastroenterology
- Hepatology
- Vascular Biology
Background:
- Porto-sinusoidal vascular disease (PSVD) is an underdiagnosed condition in pediatric medicine.
- Understanding its clinical presentations, histological features, and outcomes in children is crucial.
Purpose of the Study:
- To delineate the clinical phenotypes of pediatric PSVD.
- To analyze the histological characteristics associated with different PSVD presentations.
- To evaluate the medium-term outcomes of children diagnosed with PSVD.
Main Methods:
- A retrospective multicenter study involving 62 children diagnosed with PSVD.
- Histopathology reports were reviewed by expert liver pathologists for accurate diagnosis.
- Patients were categorized into groups based on the presence or absence of portal hypertension.
Main Results:
- Two distinct phenotypes were identified: 58% with non-cirrhotic portal hypertension (PH-PSVD) and 42% with elevated transaminases without PH (noPH-PSVD).
- Obliterative portal venopathy was more prevalent in the PH-PSVD group, while hypervascularised portal tracts were more common in the noPH-PSVD group.
- In the PH-PSVD group, 8% required TIPS, 14% developed pulmonary vascular complications, and 19% needed liver transplantation; the noPH-PSVD group showed no progression or complications.
Conclusions:
- Pediatric PSVD manifests as two distinct clinical phenotypes: one with portal hypertension and another with isolated hypertransaminasemia.
- Histological differences between these phenotypes are subtle.
- Children with PSVD and portal hypertension face a risk of disease progression and complications, whereas those without portal hypertension have a favorable medium-term outcome.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
241
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
241
Cardiomyopathy III: Hypertrophic Cardiomyopathy
17
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
17
Pleiotropy
40.7K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
40.7K
Mitral Stenosis II: Clinical features and Diagnostic Tests
26
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
26


